Target intelligence / Profile preview

Host hepatocyte surface attachment factors

Molecular classification
Receptor, Transporter, Glycoprotein, Proteoglycan
01

Overview

Host hepatocyte surface attachment factors represent a heterogeneous group of molecules on the liver cell membrane that pathogens utilize for docking and entry. These factors include proteins like the sodium taurocholate cotransporting polypeptide (NTCP), scavenger receptor class B type I (SR-BI), and CD81, as well as heparan sulfate proteoglycans (HSPGs) (Yan et al., 2012, eLife; Zeisel et al., 2013, Journal of Hepatology). Their primary physiological functions often involve the transport of bile acids, lipids, or signaling molecules, which are hijacked by viruses such as HBV, HCV, and HDV, or parasites like Plasmodium (Silvie et al., 2003, Nature Medicine). In the context of Hepatitis B and D, NTCP is the definitive receptor, and its inhibition prevents the virus from infecting new hepatocytes. For Hepatitis C, a multi-step entry process involves initial attachment to HSPGs followed by interaction with SR-BI, CD81, and tight junction proteins (Barth et al., 2003, JBC). Therapeutic agents targeting these factors, such as the entry inhibitor bulevirtide, provide a mechanism to interrupt the viral life cycle at the earliest stage. However, because these factors perform essential host functions, drug development must balance antiviral efficacy with the risk of metabolic disruption, such as altered bile acid homeostasis. Monitoring biomarkers like serum bile acids or viral load is crucial for assessing the safety and efficacy of such interventions.

Other names
Hepatocyte entry receptorsLiver cell attachment factorsViral entry factorsHepatocyte surface receptors
02

Mechanism of action

Inhibition of pathogen attachment and entry into host hepatocytes by blocking specific surface receptors or attachment factors.

03

Biological functions

Bile acid transportLipid metabolismCell adhesionViral entryParasite entry
04

Disease associations

InfectionHepatitis BHepatitis CHepatitis DMalaria
05

Safety considerations

Hypercholanemia (elevated bile acids)Disruption of lipid homeostasisPotential for compensatory upregulation of alternative entry pathwaysOff-target effects on tight junction integrity
06

Interacting drugs

Bulevirtide

3 more in the full profile.

07

Biomarkers

Serum bile acidsHBV DNAHDV RNAHCV RNAAlanine aminotransferase (ALT)

Beyond the preview

Go deeper on Host hepatocyte surface attachment factors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host hepatocyte surface attachment factors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call